Howard Clark is Professor of Neonatal Medicine and Child Health and Immediate Past President of the Neonatal Society- the foremost research society in Neonatal Medicine in Europe. His research focuses on developing new therapeutic intervention for neonatal lung disease based on his internationally recognised expertise in lung surfactant proteins. This work has been recognised by substantial awards from the Medical Research Council to carry out first in man trials of novel surfactant protein immunotherapy.
Targeted Lung Immunotherapy Group
Howard's research focuses on developing new therapeutic intervention for neonatal lung disease based on his internationally recognised expertise in lung surfactant proteins.